Ben is the Scientific Founder and CSO of Infinity Bio, Inc., a company that offers deep antibody profiling using MIPSA technology. He is also an Associate Professor of Pathology at Johns Hopkins School of Medicine. The Larman Laboratory develops and deploys new technologies to study the human immune system and its response to self and environmental exposures.
Ben received his B.S. in Engineering Physics and Bioengineering from UC Berkeley and a Ph.D. from Harvard-MIT's Division of Health Sciences & Technology, followed by a postdoctoral fellowship at The Scripps Research Institute.
